Tubidy
    Efficacy and safety of secukinumab in psoriasis over 5 years, R. Langley et al.

    Efficacy and safety of secukinumab in psoriasis over 5 years, R. Langley et al.

    06:00 |
    Download MP3

    Related Videos

    British journal of dermatology study 6:02

    British journal of dermatology study

    Epidemiology of alopecia areata, M. Augustin et al 2:57

    Epidemiology of alopecia areata, M. Augustin et al

    Dr. Cynthia Magro explains her recent British Journal of Dermatology paper. 22:42

    Dr. Cynthia Magro explains her recent British Journal of Dermatology paper.

    AI for the detection of melanoma in primary care, P. Papachristou et al. 2:04

    AI for the detection of melanoma in primary care, P. Papachristou et al.

    Epidemiology and HCRU for GPP, PPP and plaque psoriasis in England, M. Frysz et al. 2:53

    Epidemiology and HCRU for GPP, PPP and plaque psoriasis in England, M. Frysz et al.

    AI-driven immunofluorescence pattern recognition in AIBDs, N. Capurro et al. 1:49

    AI-driven immunofluorescence pattern recognition in AIBDs, N. Capurro et al.

    Dermatology in the Time of COVID-19 49:14

    Dermatology in the Time of COVID-19

    Insulin resistance and response to psoriasis treatment, D. Huang et al. 2:33

    Insulin resistance and response to psoriasis treatment, D. Huang et al.

    Quality of reporting in SRs published in dermatology journals, D.O. Croitoru et al 2:21

    Quality of reporting in SRs published in dermatology journals, D.O. Croitoru et al

    BAD guidelines for prescribing oral ciclosporin, 2018, J. Berth-Jones et al 2:28

    BAD guidelines for prescribing oral ciclosporin, 2018, J. Berth-Jones et al

    Experiences of resuming life after immunotherapy, Kamminga et al 2:05

    Experiences of resuming life after immunotherapy, Kamminga et al

    Phase III study of xeligekimab in moderate–severe plaque psoriasis, L. Cai et al. 4:33

    Phase III study of xeligekimab in moderate–severe plaque psoriasis, L. Cai et al.

    The CXCR4–CXCR7–CXCL12 axis in primary melanoma, A.T. McConnell et al 4:31

    The CXCR4–CXCR7–CXCL12 axis in primary melanoma, A.T. McConnell et al

    Risk of serious infection associated with psoriasis, Yiu et al 4:42

    Risk of serious infection associated with psoriasis, Yiu et al

    Efficacy and safety of secukinumab in psoriasis over 5 years, R. Langley et al. 6:01

    Efficacy and safety of secukinumab in psoriasis over 5 years, R. Langley et al.

    Interview with John Ingram, Editor-in-Chief 3:26

    Interview with John Ingram, Editor-in-Chief

    A clinical and biological review of keratoacanthoma, A. Tisack et al 2:08

    A clinical and biological review of keratoacanthoma, A. Tisack et al

    Validation of electronic DLQI, F.M. Ali et al 3:02

    Validation of electronic DLQI, F.M. Ali et al

    Surgical re-excision vs. observation for dysplastic naevi, K.T. Vuong et al. 4:05

    Surgical re-excision vs. observation for dysplastic naevi, K.T. Vuong et al.

    Evidence-based treatments for rosacea based on phenotype approach, van Zuuren et al 5:02

    Evidence-based treatments for rosacea based on phenotype approach, van Zuuren et al